Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Abraxane and Avastin as Therapy for Patients With Malignant Melanoma, a Phase II Study

NCT00462423 is registered in ClinicalTrials.gov with Lynn E. Spitler, MD as lead sponsor.

NCT NCT00462423
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00462423 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Abraxane and Avastin as Therapy for Patients With Malignant Melanoma, a Phase II Study
Lead sponsor
Lynn E. Spitler, MD
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2007
Completion date
January 31, 2012
Enrollment
50 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic malignant melanoma